INHIBITORS OF SARM1 IN COMBINATION WITH NAD+ OR A NAD+ PRECURSOR

• 1. 与NAD+或NAD+前体组合的SARM1抑制剂 [P] . 中国专利： CN112955150A . 2021-06-11
• 2. SARM1 NAD酶活性抑制剂及其用途 [P] . 中国专利： CN110545804A . 2019-12-06
• 3. INHIBITORS OF SARM1 IN COMBINATION WITH NAD+ OR A NAD+ PRECURSOR [P] . EP3866811A1 . 2021-08-25

  机译： SARM1的抑制剂与NAD +或NAD +前体组合

• 4. COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR [P] . EP3810120A2 . 2021-04-28

  机译： 使用烟酰胺腺嘌呤二核苷酸（NAD +）前体和至少一种酮或酮前体的组合物和方法

• 5. COMPOSITIONS AND METHODS USING A NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR AND AT LEAST ONE KETONE OR KETONE PRECURSOR [P] . US2021121488A1 . 2021-04-29

  机译： 使用烟酰胺腺嘌呤二核苷酸（NAD +）前体和至少一种酮或酮前体的组合物和方法

• 1. A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor [J] . Judith Giroud-Gerbetant, Magali Joffraud, Maria Pilar Giner, Molecular Metabolism . 2019,第4期
• 2. INTERCELLULAR AND INTRACELLULAR TRAFFICKING OF NAD+ AND NAD+ PRECURSORS, INTERMEDIATE METABOLITES AND SIGNAL METABOLITES [J] . Antonio De Flora Journal of the Siena Academy of Sciences . 2011,第1期
• 3. Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. [J] . Klaidman L, Morales M, Kem S, Pharmacology: International Journal of Experimental and Clinical Pharmacology . 2003,第3期
• 4. NAD モデル Ru 錯体における NAD+/NADH 型光変換反応 [C] . 齋藤 翼, 柘植 清志, 大津 英揮 日本化学会春季年会講演予稿集 . 2018
• 5. Boron complexation with NAD+ inhibits ADP-ribosyl cyclase non-competitively. [D] . Kim, Danny Hyunsoo. 2005
• 6. c-Jun N-terminal kinase (JNK)-mediated phosphorylation of SARM1 regulates NAD+ cleavage activity to inhibit mitochondrial respiration [O] . Hitoshi Murata, Cho Cho Khine, Akane Nishikawa, 2018
• 7. Characterization of nonspecific inhibition of the sirtuins by substrate NAD+ precursors and inhibitors of other NAD+-utilizing enzymes [O] . Azar Richard Julian 2009

• 1. 饲养密度对仔猪血清抗氧化、肝脏NAD+/NADH及嘧啶核苷酸代谢基因表达的影响 [J] . 鲍彤彤 ,郜陆敏 ,张玉梅 . 东北农业大学学报 . 2021,第002期
• 2. MDA、GSH-Px、NAD+/NADH氧化还原失衡与2型糖尿病关系的研究进展 [J] . 范茗华 ,罗晓婷 . 赣南医学院学报 . 2021,第009期
• 3. 桥联黄素再生NAD+耦联L-谷氨酸脱氢酶高效产α-酮戊二酸 [J] . 谭卓涛 ,付静雯 ,张肖旺 . 生物加工过程 . 2021,第002期
• 4. NAD+代谢与衰老及其运动适应研究进展 [J] . 蒋智 ,田子林 ,胡帅 . 体育科研 . 2021,第005期
• 5. Sirtuins激动剂(NAD+)在心血管疾病治疗中的研究进展 [J] . 王鑫垚 ,吕风华 . 临床医学研究与实践 . 2021,第026期
• 6. 新抑制剂及植物线粒体内膜外侧NAD(P)脱氢酶的识别New Inhibiters and Identification of External NAD（P）HDehydrogenases in the Potate Tuber Miltochondria [C] . . 中国科协第三届青年学术年会 . 1998
• 7. Bcl-2家族抑制剂ApoG2和NAD(P)H过氧化物酶抑制剂DPI抗鼻咽癌作用及分子机理 [A] . 胡哲煜 . 2009